Society Testimony

Location: Home > Advocacy > Legislative > Society Testimony

Society Testimony

2010

Testimony from The Endocrine Society to the FDA on the Safety of Avandia

FY 2011 House Appropriations Testimony Regarding NIH Funding

2008

Testimony of Robert Vigersky, MD, Colonel, Medical Corps to the FDA on Approval of Diabetes Medication ( PDF file

PDF file

- 34 KB)

Testimony of Dr. Alan D. Rogol on HGH, presented to the House Government Reform Committee ( PDF file

PDF file

- 93 KB)

2007

President Wartofsky Testimony to Senate Special Committee on Aging on Biodentical Hormones ( PDF file

PDF file

- 24 KB)

Public Testimony Submitted to the FDA on Rosiglitazone ( PDF file

PDF file

- 48 KB)

2005

Testimony of Carolyn Becker, MD, to the New York Medicaid Pharmacy and Therapeutics Committee on Levothyroxine Bioequivalence

2004

Testimony of E. Chester Ridgway, MD, to the House Appropriations Committee on FY 2005 NIH Funding

Testimony of Daniel Spratt, MD, to the House Government Reform Committee on Obesity

2000

Testimony of Marvin Gershengorn, MD, to the House Appropriations Committee on FY 2001 NIH Funding

Created by Matrix Group International Inc.